Sol-Gel Technologies Ltd. (SLGL)
NASDAQ: SLGL · Real-Time Price · USD
0.4913
-0.0287 (-5.52%)
At close: Apr 1, 2025, 4:00 PM
0.5687
+0.0774 (15.75%)
After-hours: Apr 1, 2025, 4:25 PM EDT
Sol-Gel Technologies Employees
Sol-Gel Technologies had 36 employees as of December 31, 2023. The number of employees decreased by 19 or -34.55% compared to the previous year.
Employees
36
Change (1Y)
-19
Growth (1Y)
-34.55%
Revenue / Employee
$325,194
Profits / Employee
-$265,833
Market Cap
13.69M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 400,000 |
Johnson & Johnson | 138,100 |
Thermo Fisher Scientific | 125,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 92,900 |
Novo Nordisk | 77,349 |
Novartis AG | 75,883 |
Merck & Co. | 75,000 |
SLGL News
- 4 months ago - Sol-Gel Reports Third Quarter 2024 Financial Results and Provides Corporate Updates - GlobeNewsWire
- 8 months ago - UPDATE: Sol-Gel Reports Second Quarter 2024 Financial Results and Provides Corporate Updates - GlobeNewsWire
- 8 months ago - Sol-Gel Reports Second Quarter 2024 Financial Results and Provides Corporate Updates - GlobeNewsWire
- 9 months ago - Sol-Gel Technologies Announces Management Realignment - GlobeNewsWire
- 11 months ago - Sol-Gel Reports First Quarter 2024 Financial Results and Provides Corporate Updates - GlobeNewsWire
- 11 months ago - Sol-Gel and Beimei Pharma Announce an Asset Purchase Agreement to Commercialize TWYNEO® in the Mainland of China, Hong Kong, Macau, Taiwan and Israel - GlobeNewsWire
- 1 year ago - Sol-Gel's Collaboration Partner First-to-File ANDA Drug Product Generic to Zoryve® Cream - GlobeNewsWire
- 1 year ago - Sol-Gel Reports Full-Year 2023 Financial Results and Corporate Developments - GlobeNewsWire